Graf Acquisition Corp. IV (NYSE:GFOR) has closed its combination with NKGen Biotech and its shares and warrants will begin trading on the Nasdaq under the symbols “NKGN” and “NKGNW” today.
The SPAC secured shareholder approval for the deal last week with 84.3% redemptions. Graf IV CEO James Graf is set to join the combined company as its interim CFO.
The $160 million combination was initially announced in April of this year. Santa Ana, California-based NKGen has five pharmaceutical formulas that have each reached some stage of Phase I and Phase II clinical trials seeking potential therapies for cancer and neurodegenerative conditions like Parkinson’s and Alzheimer’s.
The company expects to release interim data from its Phase I trials for drug candidate SNK-02 for solid tumor treatments before the end of 2023.
ADVISORS
- Company
- Cooley LLP is acting as legal advisor to NKGen and NKMax.
- Sponsor
- White & Case LLP is acting as legal advisor to Graf.
At the SPAC of Dawn A busy week of Fed speaking engagements is set to follow this week after Moody’s late Friday downgrade of US debt, which has left markets in the red through the weekend. SPACs may dodge some of the early fallout from the from the switch from AAA to AA1, as none...
Terms Tracker for the Week Ending May 16, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. It was a very, very good week for SPAC IPO trading performances. The average performance for just this week alone clocked in at an average...
At the SPAC of Dawn The faucet of new SPACs to market is fully open with two more new SPACs pricing overnight and Churchill X (NASDAQ:CCCXU) already fully over-allotted after its May 14 IPO. Of the two IPOs Wen Acquisition Corp (NASDAQ:WENNU) showed particular speed, having filed its initial S-1 just over two weeks ago...
Columbus Circle Capital Corp I (NASDAQ:CCCMU) announced the pricing of its upsized $220 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCCMU”, Friday, May 16, 2025. The new SPAC aims to conduct a broad search for a target with a team that has expertise in telecoms, media,...
Wen Acquisition Corp (NASDAQ:WENNU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “WENNU”, Friday, May 16, 2025. The new SPAC aims to combine with a fintech target focused on enabling digital assets through the integration of blockchain networks into traditional financial...